Healthcare Burden Shifts as Hospitalisation Risk Doubles After Age 45

IMT News Desk
IMT News Desk
· 2 min read
New NSO data reveals that hospitalisation risk in India doubles after age 45

Recent data from the National Sample Survey Office (NSO) indicates that the risk of hospitalisation in India doubles once individuals surpass the age of 45, highlighting a significant transition in the nation’s healthcare landscape.

According to the survey covering the last 365 days, hospitalisation rates rise from 23 per 1,000 people in the 30 to 44 age demographic to 42 per 1,000 for those aged 45 to 59, further escalating to 81 per 1,000 for individuals aged 60 and above. In comparison, younger cohorts aged 15–29 show a significantly lower rate of 15 per 1,000, underscoring the growing concentration of healthcare demand among middle-aged and older populations.

Medical experts attribute this upward trend to an increasing burden of chronic conditions, including diabetes, hypertension, heart disease, and respiratory illnesses. A sharp rise in hospital admissions after 45 suggests a systemic gap in preventive healthcare. While lifestyle-related diseases are manifesting earlier, structured screening and risk mitigation efforts have not kept pace, leaving a critical need for enhanced primary healthcare and early disease management to reduce avoidable admissions.

Regional variations in these data points reflect broader disparities, with Kerala reporting one of the highest hospitalisation rates for the elderly at 186 per 1,000, which is more than double the national average. Although higher figures in certain states may partly indicate improved healthcare access and better illness detection, the overall national trend signals a mounting pressure on inpatient care infrastructure. As India’s population continues to age, the findings emphasize an urgent necessity for strategies that prioritize long-term care management to address the shifting needs of a maturing demographic.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk